• Aboriginal and Torres Strait Islander Health Performance Framework
    • Australian Mesothelioma Registry
    • GEN Aged Care Data
    • Housing data
    • Metadata Online Registry (METEOR)
    • Regional Insights for Indigenous Communities
  • Contact us
  • Help & tools
  • Increase text size
  • Decrease text size
Home - Australian Government - Australian Institute of Health and Welfare - logo AIHW - logo
  • Home
  • Reports & data Use down arrow to expand
    Reports & data

    Find reports & data by topic

    • A
    • B
    • C
    • D
    • E
    • F
    • G
    • H
    • I
    • J
    • K
    • L
    • M
    • N
    • O
    • P
    • Q
    • R
    • S
    • T
    • U
    • V
    • W
    • X
    • Y
    • Z
    See all topics
    • Latest releases
    • Educational resources

    Featured

    • Australia's health
    • Australia's welfare
    • Australia's health performance
    • Hospitals
    • Australia’s Disability Strategy
    • Linked data assets
    • First Nations people
    • Suicide & self-harm monitoring
    • Family, domestic & sexual violence
    • Australian Centre for Monitoring Population Health
  • About our data Use down arrow to expand
    About our data
    • Our data collections
    • AIHW data by geography
    • AIHW data by indicators
    • AIHW data by sex and gender
    • Accessing data through the AIHW
    • Data governance
    • Other government data
    • AIHW linked data assets
    • Statistical terms and concepts
    • Vulnerability and disclosure policy
  • Our services Use down arrow to expand
    Our services
    • Data integration
    • Metadata support
    • Validata
    • Ethical (HREC) review
  • About us Use down arrow to expand
    About us
    • Our role & organisation goals
    • Our people & structure
    • Our governance
    • Our committees
    • Our impact
    • Our international role
    • Careers
    • Corporate publications
    • Freedom of Information
    • Gifts & benefits register
    • Modern slavery
    • Privacy
    • Public interest disclosure
    • Reporting suspected fraud
    • Scam warning
    • Submissions to inquiries
    • Tenders
  • Newsroom Use down arrow to expand
    Newsroom
    • Media releases
    • Latest news & events
    • Upcoming releases
    • Our podcast – Behind the data
    • Aboriginal and Torres Strait Islander Health Performance Framework
    • Australian Mesothelioma Registry
    • GEN Aged Care Data
    • Housing data
    • Metadata Online Registry (METEOR)
    • Regional Insights for Indigenous Communities
  • Contact us
  • Help & tools
  • Increase text size
  • Decrease text size
You are here: Home Reports & data Alcohol & other drug treatment services Alcohol and other drug treatment services in Australia annual report 2024–25 Insights
You are here:Go to Alcohol & other drug treatment services
Share via Facebook Share via Twitter Share via Linkedin Share via email

Alcohol and other drug treatment services in Australia annual report 2024–25

Web report
Last updated: 25 Jun 2026
Topic: Alcohol & other drug treatment services

Citation

AIHW (Australian Institute of Health and Welfare) (2026) Alcohol and other drug treatment services in Australia annual report 2024–25, AIHW, Australian Government, accessed 25 June 2026.

Get citation (EndNote)

PDF | 8.6MB

Save web report
Show navigation
Skip to page content
Back to topic
  • Contents

    • About
    • Insights
    • Clients
      • Client profile
      • Aboriginal and Torres Strait Islander (First Nations) people
    • Drugs of concern
      • Trends in drugs of concern
      • Alcohol
      • Methamphetamine
      • Cannabis
      • Heroin
      • Pharmaceuticals
      • Selected other drugs
    • Treatment provided
      • Trends in treatment provided
      • Assessment only
      • Counselling
      • Information and education
      • Pharmacotherapy
      • Rehabilitation
      • Support and case management
      • Withdrawal management
      • Other main treatment
    • Treatment referral and completion
      • Trends in treatment referral and completion
      • Duration of treatment
      • Completion of treatment
    • Agencies
      • Trends in agencies
      • Service sector
      • Location of agencies
    • State and territory summaries
      • Trends in clients in states and territories
      • New South Wales
      • Victoria
      • Queensland
      • Western Australia
      • South Australia
      • Tasmania
      • Australian Capital Territory
      • Northern Territory
      • Technical notes - state and territory summaries
    • Data – pharmacotherapy in Australia
    • Geography data for Primary Health Networks (PHNs)
    • Data – diversion programs in Australia
    • Technical notes
      • Policy framework
      • Data and methods
      • State and territory data quality
      • Key terminology
      • Acronyms
      • Geography data for Primary Health Networks (PHN)
      • Pharmacotherapy in Australia
  • Notes
  • Data
  • Report editions
  • Related material
  • Archived content

Insights

Clients

  • Around 127,800 people aged 10 and over received 244,400 alcohol or other drug (AOD) treatment episodes in 2024–25

  • Since 2019–20, the number of clients in AOD services has dropped by 8.2%, falling from 139,295 to 127,804, while rates have fallen from 623 to 527 per 100,000 people

Principal drugs of concern

  • The most common principal drug of concern was alcohol (41%, 87,600 episodes), followed by methamphetamine (24%), cannabis (14%) and heroin (4.3%)

  • 63200 87600 2015-16 2024-25

    Alcohol has remained the most common principal drug of concern, increasing since 2015-16

AOD treatment

  • 88% of all AOD treatment episodes were provided to people receiving treatment for their own drug use while a further 12% were for someone else’s AOD use

  • From 2015–16, the number of AOD treatment episodes rose by 18% from 206,395 in 2015–16 to 244,411 in 2024–25

  • In 2024–25, 3 in 5 (59%, 143,496) treatment episodes ended as an expected or planned completion and has remained similar since 2015–16

  • The median length of AOD treatment was four weeks for clients’ own AOD use and two weeks for clients who received support for someone else’s AOD use

AOD agencies

  • Nationally, over the 10-year period to 2024–25, the total number of publicly funded agencies providing AOD treatment increased by 66% from 791 in 2015–16 to 1,316 in 2024–25

  • Over half of all AOD agencies (55%) were located in Major cities

Previous page
Next page

Last updated 02/06/2026 v5.0

AIHW

  • About us
  • Our committees
  • Our governance
  • Our reports
  • Our data
  • Newsroom

Using AIHW

  • Accessibility
  • Copyright
  • Disclaimer
  • Freedom of Information
  • Indexed list of files
  • Privacy
  • Site map
  • Vulnerability and disclosure policy

Quick links

  • Home
  • AIHW Ethics Committee
  • Careers
  • Crisis and support services
  • Our data collections
  • Data integration
  • Data on request
  • Login

Connect with us

Connect with AIHW on LinkedIn Follow AIHW on Instagram Visit AIHW on YouTube

© Australian Institute of Health and Welfare 2026

Creative Commons

Search

Keep typing to see search results...

Sorry, we couldn't find any results matching

To help find what you're looking for:

  • Check your spelling and try again
  • using a more general term
  • keep your search term short and simple
  • try looking in A-Z topics

Other ways to browse

A-Z Topics

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

Close

Feedback

We'd love to know any feedback that you have about the AIHW website, its contents or reports.

Required fields

The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.